Clinical trial
Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
NCT03745586 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 1, 2018
- Completion date
- March 1, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.